Labomar Group introduces CLT 25 – ChoLnexT™ 25

Labomar Group introduces CLT 25 – ChoLnexT™ 25, a new frontier in cholesterol management, developed through an advanced scientific approach and a smart combination of patent-pending botanical extracts.

This is not just a simple ingredient, but a new way of thinking about supporting lipid metabolism: more targeted, more synergistic, and in line with the needs of a constantly evolving market. An innovative solution, free of red yeast rice and berberine, backed by clinical data.

CLT 25 represents a concrete evolution in the field of nutraceutical formulations, combining science-driven innovation, an advanced formulation approach, and a design geared toward the next generation of nutraceutical solutions.

For more details, read the full press release.